| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
36,049 |
27,362 |
$7.33M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
35,985 |
32,742 |
$6.26M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
47,299 |
43,520 |
$6.23M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
61,058 |
56,766 |
$5.93M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
24,672 |
18,714 |
$2.80M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
57,111 |
51,156 |
$2.67M |
| A0425 |
Ground mileage, per statute mile |
65,932 |
50,594 |
$1.63M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39,170 |
33,658 |
$1.17M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
30,836 |
27,826 |
$988K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
9,390 |
8,391 |
$907K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,508 |
2,214 |
$807K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,903 |
3,686 |
$790K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
9,856 |
8,104 |
$619K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
4,311 |
3,381 |
$425K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
20,474 |
17,065 |
$423K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
19,646 |
16,448 |
$408K |
| 80053 |
Comprehensive metabolic panel |
60,129 |
52,036 |
$404K |
| 81514 |
|
2,551 |
2,361 |
$394K |
| 43775 |
|
192 |
142 |
$374K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,989 |
7,367 |
$308K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
60,823 |
52,628 |
$297K |
| A0433 |
Advanced life support, level 2 (als 2) |
1,040 |
892 |
$270K |
| 72114 |
|
3,627 |
3,396 |
$265K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,111 |
7,089 |
$245K |
| 71046 |
Radiologic examination, chest; 2 views |
6,461 |
5,946 |
$244K |
| 72050 |
|
2,388 |
2,250 |
$240K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,462 |
5,963 |
$232K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,464 |
1,316 |
$221K |
| 93017 |
|
2,090 |
1,919 |
$220K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,440 |
5,719 |
$215K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
537 |
518 |
$205K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,178 |
3,026 |
$201K |
| 71045 |
Radiologic examination, chest; single view |
7,420 |
6,787 |
$198K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,455 |
5,962 |
$196K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,197 |
2,018 |
$182K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
8,963 |
7,295 |
$182K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,362 |
3,748 |
$180K |
| 81025 |
|
29,155 |
26,128 |
$177K |
| 36415 |
Collection of venous blood by venipuncture |
84,395 |
68,190 |
$164K |
| 76830 |
Ultrasound, transvaginal |
2,530 |
2,325 |
$154K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,379 |
1,206 |
$150K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,454 |
1,287 |
$135K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,441 |
2,090 |
$126K |
| A0428 |
Ambulance service, basic life support, non-emergency transport, (bls) |
8,276 |
6,660 |
$122K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
280 |
261 |
$116K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,073 |
3,528 |
$114K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
291 |
283 |
$112K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
3,659 |
3,409 |
$111K |
| 59025 |
Fetal non-stress test |
1,584 |
743 |
$103K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
624 |
578 |
$101K |
| 84484 |
|
14,008 |
10,636 |
$90K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,305 |
2,958 |
$86K |
| 72141 |
|
219 |
203 |
$86K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,147 |
594 |
$85K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
372 |
355 |
$84K |
| G0378 |
Hospital observation service, per hour |
837 |
363 |
$74K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,364 |
2,266 |
$71K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
562 |
349 |
$64K |
| 0002A |
|
1,862 |
1,656 |
$62K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,274 |
1,204 |
$62K |
| 0001A |
|
1,812 |
1,676 |
$56K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
134 |
118 |
$54K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,646 |
1,473 |
$49K |
| 99215 |
Prolong outpt/office vis |
1,041 |
842 |
$48K |
| 94729 |
|
1,382 |
1,319 |
$48K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
126 |
117 |
$45K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
171 |
153 |
$41K |
| 81003 |
|
23,832 |
21,329 |
$38K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
643 |
338 |
$34K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
85 |
78 |
$32K |
| 93356 |
|
541 |
505 |
$28K |
| 80061 |
Lipid panel |
2,663 |
2,450 |
$28K |
| 83690 |
|
5,933 |
5,346 |
$27K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
561 |
454 |
$26K |
| 83880 |
|
1,383 |
1,267 |
$26K |
| 82962 |
|
15,861 |
9,694 |
$25K |
| 94010 |
|
712 |
677 |
$25K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
629 |
474 |
$24K |
| 80050 |
General health panel |
590 |
544 |
$23K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
66 |
63 |
$23K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
106 |
52 |
$22K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
136 |
127 |
$20K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
73 |
69 |
$20K |
| 31255 |
|
35 |
25 |
$19K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
70 |
69 |
$18K |
| 30117 |
|
256 |
139 |
$16K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
821 |
720 |
$16K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
113 |
93 |
$15K |
| 93880 |
|
323 |
295 |
$15K |
| 85027 |
|
2,927 |
2,621 |
$14K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,954 |
1,789 |
$14K |
| 0004A |
|
414 |
337 |
$14K |
| 82728 |
|
1,379 |
1,242 |
$13K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
32 |
28 |
$12K |
| 87430 |
|
800 |
759 |
$12K |
| 94726 |
|
234 |
222 |
$12K |
| 87070 |
|
1,238 |
1,111 |
$10K |
| 96523 |
|
552 |
439 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,303 |
1,122 |
$8K |
| A0998 |
Ambulance response and treatment, no transport |
6,945 |
5,996 |
$8K |
| 81001 |
|
3,901 |
3,502 |
$7K |
| 93226 |
|
77 |
54 |
$7K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
17 |
17 |
$7K |
| 72110 |
|
90 |
88 |
$7K |
| 73522 |
|
57 |
56 |
$7K |
| J2785 |
Injection, regadenoson, 0.1 mg |
201 |
185 |
$6K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
130 |
72 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,050 |
2,110 |
$6K |
| 72072 |
|
77 |
73 |
$6K |
| 93225 |
|
77 |
54 |
$6K |
| 84466 |
|
685 |
604 |
$6K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
12 |
12 |
$5K |
| 76770 |
|
74 |
69 |
$5K |
| 77336 |
|
104 |
37 |
$5K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
191 |
179 |
$5K |
| 83540 |
|
1,122 |
1,001 |
$5K |
| 71250 |
|
25 |
25 |
$5K |
| 30520 |
|
15 |
13 |
$5K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
541 |
517 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,620 |
2,210 |
$5K |
| 81002 |
|
1,658 |
1,475 |
$5K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,944 |
1,576 |
$5K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
182 |
56 |
$4K |
| 96367 |
|
78 |
50 |
$4K |
| 74220 |
|
57 |
51 |
$4K |
| 97162 |
|
71 |
69 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,435 |
2,264 |
$4K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
1,043 |
986 |
$4K |
| 82550 |
|
1,125 |
990 |
$4K |
| 78803 |
|
18 |
16 |
$4K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
82 |
79 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
519 |
451 |
$4K |
| 87040 |
|
380 |
340 |
$3K |
| 85730 |
|
1,120 |
961 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
243 |
226 |
$3K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
3,679 |
2,289 |
$3K |
| 83605 |
|
459 |
393 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
127 |
116 |
$3K |
| 0013A |
|
74 |
70 |
$3K |
| 87150 |
|
87 |
85 |
$3K |
| 87400 |
|
388 |
358 |
$3K |
| 72082 |
|
58 |
57 |
$3K |
| 31295 |
|
343 |
179 |
$3K |
| 85610 |
|
1,159 |
1,007 |
$3K |
| 87081 |
|
224 |
216 |
$2K |
| 30140 |
|
1,133 |
746 |
$2K |
| 85007 |
|
1,074 |
949 |
$2K |
| 72100 |
|
57 |
53 |
$2K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
285 |
266 |
$2K |
| 83550 |
|
345 |
317 |
$2K |
| 83735 |
|
604 |
521 |
$2K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
68 |
63 |
$2K |
| 86756 |
|
140 |
137 |
$2K |
| 94727 |
|
117 |
110 |
$2K |
| 90674 |
|
277 |
249 |
$2K |
| J1750 |
Injection, iron dextran, 50 mg |
19 |
12 |
$2K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
104 |
102 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
16 |
15 |
$2K |
| 85379 |
|
273 |
242 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
40 |
39 |
$2K |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
36 |
12 |
$1K |
| 86850 |
|
263 |
225 |
$1K |
| C9113 |
Injection, pantoprazole sodium, per vial |
356 |
182 |
$1K |
| 93296 |
|
305 |
287 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
264 |
185 |
$1K |
| 77417 |
|
50 |
24 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
26 |
25 |
$1K |
| 72074 |
|
13 |
12 |
$1K |
| 80320 |
|
133 |
93 |
$1K |
| 90677 |
|
14 |
12 |
$1K |
| 93298 |
|
143 |
140 |
$1K |
| 84460 |
|
204 |
197 |
$1K |
| 82947 |
|
405 |
302 |
$1K |
| 84450 |
|
204 |
197 |
$1K |
| 90715 |
|
32 |
30 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,732 |
1,267 |
$942.85 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
149 |
133 |
$940.96 |
| 82553 |
|
193 |
154 |
$918.02 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
56 |
25 |
$914.44 |
| 84425 |
|
50 |
46 |
$912.89 |
| 90651 |
|
13 |
13 |
$873.84 |
| 94664 |
|
20 |
14 |
$833.22 |
| 86780 |
|
74 |
65 |
$820.88 |
| 84439 |
|
109 |
103 |
$803.65 |
| 74018 |
|
20 |
16 |
$780.98 |
| 83874 |
|
190 |
153 |
$770.37 |
| 82150 |
|
190 |
165 |
$758.16 |
| 84703 |
|
101 |
96 |
$729.44 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
17 |
17 |
$718.62 |
| 86803 |
|
56 |
52 |
$699.23 |
| 94618 |
|
13 |
13 |
$684.18 |
| 92557 |
|
18 |
18 |
$683.20 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
177 |
86 |
$657.88 |
| 85045 |
|
230 |
212 |
$655.93 |
| 82607 |
|
50 |
46 |
$648.44 |
| 86900 |
|
280 |
237 |
$646.30 |
| 86901 |
|
280 |
237 |
$646.30 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
527 |
457 |
$644.37 |
| 90682 |
|
73 |
62 |
$643.70 |
| 0003A |
|
16 |
16 |
$593.28 |
| 82043 |
|
116 |
109 |
$520.20 |
| 87340 |
|
55 |
51 |
$495.84 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
20 |
17 |
$489.18 |
| 82570 |
|
116 |
109 |
$466.20 |
| 94761 |
|
37 |
27 |
$452.32 |
| 93299 |
|
47 |
39 |
$387.22 |
| J1644 |
Injection, heparin sodium, per 1000 units |
160 |
121 |
$384.33 |
| 85014 |
|
194 |
143 |
$383.94 |
| 85018 |
|
194 |
143 |
$383.94 |
| 80329 |
|
30 |
28 |
$378.81 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
48 |
38 |
$367.40 |
| 84238 |
|
14 |
13 |
$365.70 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
127 |
108 |
$312.74 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
445 |
259 |
$289.69 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
31 |
30 |
$257.95 |
| 92567 |
|
14 |
14 |
$227.10 |
| 82248 |
|
51 |
48 |
$212.96 |
| 90661 |
|
31 |
28 |
$212.40 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
43 |
40 |
$207.54 |
| 83615 |
|
48 |
42 |
$199.32 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
39 |
37 |
$186.78 |
| 87088 |
|
28 |
26 |
$186.59 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
111 |
79 |
$185.85 |
| 83655 |
|
17 |
15 |
$181.65 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,814 |
1,473 |
$176.31 |
| 84702 |
|
12 |
12 |
$165.55 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
56 |
29 |
$153.23 |
| 84480 |
|
30 |
29 |
$140.94 |
| J2704 |
Injection, propofol, 10 mg |
5,663 |
3,471 |
$135.17 |
| 86140 |
|
26 |
24 |
$113.96 |
| J7050 |
Infusion, normal saline solution, 250 cc |
109 |
73 |
$112.76 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
286 |
201 |
$105.05 |
| A6219 |
Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing |
186 |
144 |
$103.70 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
2,468 |
2,222 |
$81.62 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
20 |
12 |
$80.88 |
| 93297 |
|
12 |
12 |
$67.85 |
| 84100 |
|
26 |
24 |
$66.36 |
| 91301 |
|
78 |
74 |
$62.08 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
25 |
24 |
$51.73 |
| J1643 |
Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units |
83 |
49 |
$38.10 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
17 |
15 |
$35.52 |
| 91300 |
|
4,550 |
3,329 |
$31.22 |
| A0888 |
Noncovered ambulance mileage, per mile (e.g., for miles traveled beyond closest appropriate facility) |
1,277 |
1,097 |
$20.80 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
70 |
66 |
$18.25 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
839 |
658 |
$15.52 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,113 |
918 |
$13.93 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
288 |
231 |
$11.51 |
| C1729 |
Catheter, drainage |
277 |
258 |
$1.50 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
317 |
274 |
$0.00 |
| 99001 |
|
1,425 |
1,079 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
227 |
190 |
$0.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
8,987 |
6,585 |
$0.00 |
| G2010 |
Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment |
17 |
16 |
$0.00 |
| 31298 |
|
192 |
108 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
42 |
40 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
130 |
119 |
$0.00 |
| 61782 |
|
194 |
170 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
42 |
42 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
50 |
47 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
60 |
52 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
32 |
29 |
$0.00 |